{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/driving-speed-and-scale-more-20-phase-i-and-ib-obesity-studies-completed-time#webpage",
"url": "https://www.fortrea.com/insights/driving-speed-and-scale-more-20-phase-i-and-ib-obesity-studies-completed-time",
"name": "Driving speed and scale: More than 20 Phase I and Ib obesity studies completed on time",
"description": "Explore how early-phase obesity clinical trials were successfully delivered at scale in this Fortrea case study, with a focus on Phase I and Ib study execution, large patient recruitment, and accelerated timelines. Learn how clinical pharmacology expertise and early phase CRO services supported complex GLP-1 clinical trials and enabled efficient study delivery across global sites. Discover how strong operational planning, rapid recruitment strategies, and streamlined clinical trial outsourcing helped reduce delays and align with NDA submission timelines. This Fortrea case study highlights how optimized clinical trial delivery services can drive faster, high-quality outcomes in early-phase obesity drug development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Driving speed and scale: More than 20 Phase I and Ib obesity studies completed on time",
"item": "https://www.fortrea.com/insights/driving-speed-and-scale-more-20-phase-i-and-ib-obesity-studies-completed-time"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/driving-speed-and-scale-more-20-phase-i-and-ib-obesity-studies-completed-time#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/driving-speed-and-scale-more-20-phase-i-and-ib-obesity-studies-completed-time#webpage"
},
"headline": "Phase I & Ib Obesityv Clinical Trials Delivered on Time | Fortrea Case Study",
"description": "Explore how early-phase obesity clinical trials were successfully delivered at scale in this Fortrea case study, with a focus on Phase I and Ib study execution, large patient recruitment, and accelerated timelines. Learn how clinical pharmacology expertise and early phase CRO services supported complex GLP-1 clinical trials and enabled efficient study delivery across global sites. Discover how strong operational planning, rapid recruitment strategies, and streamlined clinical trial outsourcing helped reduce delays and align with NDA submission timelines. This Fortrea case study highlights how optimized clinical trial delivery services can drive faster, high-quality outcomes in early-phase obesity drug development.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-02-02",
"dateModified": "2026-02-02",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-02/phase-1-ib-obesity-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}